data_5ipo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ipo _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG11 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' H ' HG11 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.272 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HE2' ' N ' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.929 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.532 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 119.737 -0.173 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.34 153.93 42.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.484 1.114 . . . . 0.0 113.49 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -86.63 44.93 1.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.48 -1.387 . . . . 0.0 112.608 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.9 ptp -139.91 109.26 6.17 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.147 1.779 . . . . 0.0 108.038 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.57 9.5 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.8 -13.79 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -69.82 81.26 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.928 2.491 . . . . 0.0 110.289 168.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -77.83 3.88 13.23 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.268 2.227 . . . . 0.0 111.754 -173.475 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -76.01 167.47 21.82 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.883 2.073 . . . . 0.0 114.228 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.6 37.88 0.36 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.337 -1.477 . . . . 0.0 113.581 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.6 mtt -120.64 76.83 1.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.702 . . . . 0.0 109.094 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.5 25.03 1.25 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -168.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.93 -27.55 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -58.17 123.37 15.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.402 0.62 . . . . 0.0 111.672 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.7 -15.43 40.31 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.365 1.066 . . . . 0.0 113.826 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.668 2.787 . . . . 0.0 111.175 -175.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.94 161.84 28.16 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -171.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -94.8 76.8 3.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.818 2.047 . . . . 0.0 109.15 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptp -152.69 121.44 6.48 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.184 1.393 . . . . 0.0 107.668 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.48 13.57 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.01 -26.19 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.2 m -35.92 110.09 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.658 1.983 . . . . 0.0 114.724 -167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -65.01 -39.16 93.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 112.129 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.262 1.825 . . . . 0.0 112.153 173.289 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.435 ' CG ' ' H ' ' A' ' 3' ' ' LYS . 33.7 t60 -79.87 171.6 14.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 113.579 -175.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.435 ' H ' ' CG ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -82.46 47.42 1.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.308 2.643 . . . . 0.0 112.186 -169.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -119.22 73.4 0.94 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.802 2.041 . . . . 0.0 109.87 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.03 9.64 0.67 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.408 1.883 . . . . 0.0 115.255 -168.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.7 pp -68.96 -15.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -64.79 103.81 0.75 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.85 . . . . 0.0 110.724 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.54 22.02 1.99 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.596 1.158 . . . . 0.0 113.398 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.934 2.493 . . . . 0.0 112.089 176.197 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -172.92 4.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.267 1.827 . . . . 0.0 112.291 168.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.68 143.24 38.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 164.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.9 ptp -133.68 68.98 1.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.175 0.988 . . . . 0.0 109.64 -167.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.7 -16.16 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 128.441 2.697 . . . . 0.0 116.455 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.5 -20.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.1 m -66.53 117.23 8.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.561 1.144 . . . . 0.0 112.101 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.63 -1.08 25.05 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.585 1.154 . . . . 0.0 114.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.881 2.072 . . . . 0.0 110.31 179.688 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -75.4 176.61 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.786 1.634 . . . . 0.0 114.714 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -73.85 49.3 0.32 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.308 1.843 . . . . 0.0 113.718 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -113.57 61.24 0.65 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 110.683 -171.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.98 21.62 5.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.0 1.32 . . . . 0.0 113.894 -168.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.71 -15.25 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -77.49 77.3 4.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 109.748 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -67.55 -20.51 65.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.042 0.937 . . . . 0.0 113.229 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.61 1.964 . . . . 0.0 113.506 -172.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -143.85 159.13 43.07 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 147.04 10.23 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.984 2.114 . . . . 0.0 115.521 -173.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 ptm -153.7 53.61 0.72 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.58 -15.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.439 2.296 . . . . 0.0 115.805 -169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.97 -22.8 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -83.28 122.92 29.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.634 0.652 . . . . 0.0 110.72 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -110.37 4.41 20.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.566 1.547 . . . . 0.0 114.56 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . 0.251 3.5 pp . . . . . 0 C--O 1.253 1.244 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -141.52 -177.57 5.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 53.44 0.19 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.85 2.46 . . . . 0.0 116.309 -169.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.5 ptm -117.13 62.35 0.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.832 2.053 . . . . 0.0 109.588 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.4 24.09 9.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.871 1.669 . . . . 0.0 114.197 -167.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.67 -32.59 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.9 m -60.32 112.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -83.64 -18.41 38.2 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.636 1.575 . . . . 0.0 112.324 179.633 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 174.44 3.49 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -112.25 43.78 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -143.02 112.22 6.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.598 1.159 . . . . 0.0 109.337 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 50.9 10.19 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.787 2.435 . . . . 0.0 115.59 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG11 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' H ' HG11 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.79 -19.75 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -84.84 76.01 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.575 1.55 . . . . 0.0 109.951 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -56.84 -35.9 69.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.08 2.552 . . . . 0.0 110.636 178.26 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.65 52.65 1.94 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -169.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 43.32 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.804 1.642 . . . . 0.0 113.821 173.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 mtt -131.88 70.11 1.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.989 2.915 . . . . 0.0 107.24 -168.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.25 24.77 5.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.142 2.177 . . . . 0.0 116.138 -169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.461 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -65.08 -18.16 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 m -72.81 88.58 1.33 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.188 1.395 . . . . 0.0 110.54 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -69.57 -27.57 65.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.458 1.103 . . . . 0.0 112.519 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.303 1.841 . . . . 0.0 109.573 169.81 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -79.17 166.4 22.26 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.325 1.45 . . . . 0.0 112.771 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.16 54.15 1.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.527 -1.358 . . . . 0.0 112.331 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtp -124.68 69.22 1.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.474 2.31 . . . . 0.0 108.911 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.31 14.31 1.06 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.398 1.879 . . . . 0.0 114.94 -166.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.78 -23.4 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.4 t -82.5 111.51 18.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -93.06 39.24 1.04 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.594 1.958 . . . . 0.0 115.413 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.213 1.405 . . . . 0.0 114.423 -175.687 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.64 -0.219 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 68.96 1.13 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.962 1.305 . . . . 0.0 109.939 168.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -73.68 62.7 0.81 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.019 1.728 . . . . 0.0 114.075 -170.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -134.34 67.75 1.5 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.483 2.713 . . . . 0.0 108.675 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.74 22.49 8.5 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.293 1.837 . . . . 0.0 115.938 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.89 -16.28 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -72.88 83.89 1.22 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.305 1.442 . . . . 0.0 110.924 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -75.3 -4.61 40.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.051 1.34 . . . . 0.0 113.793 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.4 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 128.03 2.532 . . . . 0.0 110.118 -179.238 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -79.16 53.48 1.47 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.049 1.34 . . . . 0.0 112.56 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER -79.68 40.73 0.46 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -176.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.4 mtp -133.79 87.21 2.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.497 2.319 . . . . 0.0 108.091 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 8.14 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -169.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.2 -21.8 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.9 m -72.23 96.02 1.76 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.345 1.058 . . . . 0.0 110.411 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -76.84 12.5 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.253 1.267 0 C-N-CA 127.316 2.246 . . . . 0.0 112.235 179.175 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.279 0.085 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.57 -179.12 7.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.418 1.487 . . . . 0.0 112.88 176.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -100.38 45.05 0.99 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.763 1.225 . . . . 0.0 111.626 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.0 mtm -130.12 88.0 2.59 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.433 1.111 . . . . 0.0 109.318 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.96 6.43 0.22 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.118 2.167 . . . . 0.0 116.0 -167.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -64.7 -31.45 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 m 37.61 37.65 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.635 2.774 . . . . 0.0 117.579 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 45' ' ' ILE 0.257 96.5 m-85 43.68 49.42 6.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.979 2.112 . . . . 0.0 114.64 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.257 1.459 0 C-N-CA 127.308 2.243 . . . . 0.0 113.662 177.255 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.78 173.77 4.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.371 1.068 . . . . 0.0 113.688 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HB3' HE22 ' A' ' 8' ' ' GLN . 9.5 mptt -81.51 61.37 4.92 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.864 -1.148 . . . . 0.0 110.878 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 ptm -125.96 71.0 1.23 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.257 1.823 . . . . 0.0 109.941 -172.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.12 20.59 0.89 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.64 1.976 . . . . 0.0 115.6 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.407 HE22 ' HB3' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HE2' ' N ' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.59 -30.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m 33.57 37.72 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.574 3.15 . . . . 0.0 117.585 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 35.28 51.63 0.61 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.935 2.494 . . . . 0.0 114.686 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.804 2.042 . . . . 0.0 110.535 177.154 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -69.42 173.27 6.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.802 2.041 . . . . 0.0 115.28 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -73.39 39.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.731 2.012 . . . . 0.0 115.281 -177.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -115.04 77.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.477 1.911 . . . . 0.0 108.202 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 6.23 0.23 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -70.64 -15.4 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -66.74 106.44 1.85 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.801 174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -84.75 -22.47 29.63 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.264 -0.898 . . . . 0.0 113.222 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.351 2.26 . . . . 0.0 114.046 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -72.08 161.15 31.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.25 1.42 . . . . 0.0 112.716 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -78.23 50.66 0.93 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.824 1.249 . . . . 0.0 111.872 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.3 mtt -115.58 68.53 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.349 2.259 . . . . 0.0 107.873 -169.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.32 -19.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.069 2.148 . . . . 0.0 115.087 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -20.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.9 m -75.08 45.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.023 1.729 . . . . 0.0 113.477 170.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -84.44 1.78 43.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.669 1.988 . . . . 0.0 114.299 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.023 0 C-N-CA 126.749 2.02 . . . . 0.0 113.148 -179.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 119.471 -0.3 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 51.51 -145.29 0.53 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.83 1.652 . . . . 0.0 113.126 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 147.62 8.99 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.95 67.31 0.74 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.386 1.875 . . . . 0.0 109.857 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.61 -14.33 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.988 2.515 . . . . 0.0 117.121 -172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.39 -21.08 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m 38.78 49.37 1.49 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.803 2.841 . . . . 0.0 116.609 167.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 45.52 36.55 2.56 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 127.607 2.363 . . . . 0.0 115.604 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.256 1.414 0 C-N-CA 126.603 1.961 . . . . 0.0 112.966 178.559 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -78.67 150.49 32.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.476 1.11 . . . . 0.0 112.172 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -75.86 44.36 0.3 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.374 . . . . 0.0 114.642 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -135.25 101.01 4.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.382 1.473 . . . . 0.0 108.517 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.2 6.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -169.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.495 HD13 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -68.41 -32.06 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m 47.09 35.06 3.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.517 2.327 . . . . 0.0 116.766 168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.495 ' H ' HD13 ' A' ' 45' ' ' ILE . 71.7 m-85 39.27 53.51 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 114.843 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--O 1.256 1.433 0 C-N-CA 128.861 2.864 . . . . 0.0 110.558 178.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.023 0.44 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -74.9 63.35 1.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -172.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.01 48.2 0.7 Allowed 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.127 -1.608 . . . . 0.0 112.422 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -122.29 67.49 0.94 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.371 1.069 . . . . 0.0 110.32 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.07 31.79 6.93 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.947 1.299 . . . . 0.0 113.388 -167.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.532 ' H ' ' CG1' ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -27.54 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 p -77.82 27.67 0.17 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.854 2.061 . . . . 0.0 115.378 -170.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.45 -59.03 1.66 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.268 2.227 . . . . 0.0 110.099 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.951 1.3 . . . . 0.0 112.1 169.451 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 17' ' ' VAL . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 17' ' ' VAL . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' HG21 ' A' ' 17' ' ' VAL . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' HG21 ' A' ' 17' ' ' VAL . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 17' ' ' VAL . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 18' ' ' LYS . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' H ' HG12 ' A' ' 17' ' ' VAL . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HE3' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG12 ' HE3' ' A' ' 26' ' ' LYS . 2.7 pp . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB1' ' HA2' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA2' ' HB1' ' A' ' 5' ' ' ALA . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.272 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' LYS . 2.3 pp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 17' ' ' VAL . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' H ' HG12 ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.929 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.64 ' H ' HG12 ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 119.737 -0.173 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.34 153.93 42.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.484 1.114 . . . . 0.0 113.49 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -86.63 44.93 1.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.48 -1.387 . . . . 0.0 112.608 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.9 ptp -139.91 109.26 6.17 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.147 1.779 . . . . 0.0 108.038 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.57 9.5 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.8 -13.79 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -69.82 81.26 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.928 2.491 . . . . 0.0 110.289 168.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -77.83 3.88 13.23 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.268 2.227 . . . . 0.0 111.754 -173.475 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -76.01 167.47 21.82 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.883 2.073 . . . . 0.0 114.228 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.6 37.88 0.36 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.337 -1.477 . . . . 0.0 113.581 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.6 mtt -120.64 76.83 1.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.702 . . . . 0.0 109.094 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.5 25.03 1.25 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -168.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 17' ' ' VAL . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 17' ' ' VAL . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.93 -27.55 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -58.17 123.37 15.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.402 0.62 . . . . 0.0 111.672 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.7 -15.43 40.31 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.365 1.066 . . . . 0.0 113.826 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.668 2.787 . . . . 0.0 111.175 -175.91 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.94 161.84 28.16 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -171.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -94.8 76.8 3.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.818 2.047 . . . . 0.0 109.15 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptp -152.69 121.44 6.48 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.184 1.393 . . . . 0.0 107.668 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.48 13.57 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' HG21 ' A' ' 17' ' ' VAL . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' HG21 ' A' ' 17' ' ' VAL . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 17' ' ' VAL . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.01 -26.19 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.2 m -35.92 110.09 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.658 1.983 . . . . 0.0 114.724 -167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -65.01 -39.16 93.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 112.129 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.262 1.825 . . . . 0.0 112.153 173.289 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -79.87 171.6 14.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 113.579 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 47.42 1.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.308 2.643 . . . . 0.0 112.186 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -119.22 73.4 0.94 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.802 2.041 . . . . 0.0 109.87 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.03 9.64 0.67 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.408 1.883 . . . . 0.0 115.255 -168.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 18' ' ' LYS . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' H ' HG12 ' A' ' 17' ' ' VAL . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HE3' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG12 ' HE3' ' A' ' 26' ' ' LYS . 2.7 pp -68.96 -15.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -64.79 103.81 0.75 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.85 . . . . 0.0 110.724 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.54 22.02 1.99 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.596 1.158 . . . . 0.0 113.398 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.934 2.493 . . . . 0.0 112.089 176.197 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -172.92 4.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.267 1.827 . . . . 0.0 112.291 168.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.68 143.24 38.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 164.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.9 ptp -133.68 68.98 1.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.175 0.988 . . . . 0.0 109.64 -167.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB1' ' HA2' ' A' ' 10' ' ' GLY . . . 63.7 -16.16 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 128.441 2.697 . . . . 0.0 116.455 -173.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA2' ' HB1' ' A' ' 5' ' ' ALA . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.5 -20.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.1 m -66.53 117.23 8.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.561 1.144 . . . . 0.0 112.101 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.63 -1.08 25.05 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.585 1.154 . . . . 0.0 114.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.881 2.072 . . . . 0.0 110.31 179.688 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -75.4 176.61 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.786 1.634 . . . . 0.0 114.714 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -73.85 49.3 0.32 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.308 1.843 . . . . 0.0 113.718 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -113.57 61.24 0.65 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 110.683 -171.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.98 21.62 5.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.0 1.32 . . . . 0.0 113.894 -168.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.71 -15.25 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -77.49 77.3 4.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 109.748 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -67.55 -20.51 65.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.042 0.937 . . . . 0.0 113.229 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.61 1.964 . . . . 0.0 113.506 -172.934 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -143.85 159.13 43.07 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 147.04 10.23 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.984 2.114 . . . . 0.0 115.521 -173.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 ptm -153.7 53.61 0.72 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.58 -15.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.439 2.296 . . . . 0.0 115.805 -169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.97 -22.8 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -83.28 122.92 29.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.634 0.652 . . . . 0.0 110.72 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -110.37 4.41 20.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.566 1.547 . . . . 0.0 114.56 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . 0.251 3.5 pp . . . . . 0 C--O 1.253 1.244 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -141.52 -177.57 5.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 53.44 0.19 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.85 2.46 . . . . 0.0 116.309 -169.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.5 ptm -117.13 62.35 0.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.832 2.053 . . . . 0.0 109.588 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.4 24.09 9.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.871 1.669 . . . . 0.0 114.197 -167.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.67 -32.59 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.9 m -60.32 112.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -83.64 -18.41 38.2 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.636 1.575 . . . . 0.0 112.324 179.633 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 174.44 3.49 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -112.25 43.78 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -143.02 112.22 6.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.598 1.159 . . . . 0.0 109.337 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 50.9 10.19 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.787 2.435 . . . . 0.0 115.59 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.79 -19.75 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -84.84 76.01 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.575 1.55 . . . . 0.0 109.951 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -56.84 -35.9 69.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.08 2.552 . . . . 0.0 110.636 178.26 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.65 52.65 1.94 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -169.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 43.32 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.804 1.642 . . . . 0.0 113.821 173.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 mtt -131.88 70.11 1.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.989 2.915 . . . . 0.0 107.24 -168.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.25 24.77 5.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.142 2.177 . . . . 0.0 116.138 -169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -65.08 -18.16 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 m -72.81 88.58 1.33 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.188 1.395 . . . . 0.0 110.54 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -69.57 -27.57 65.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.458 1.103 . . . . 0.0 112.519 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.303 1.841 . . . . 0.0 109.573 169.81 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -79.17 166.4 22.26 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.325 1.45 . . . . 0.0 112.771 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.16 54.15 1.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.527 -1.358 . . . . 0.0 112.331 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtp -124.68 69.22 1.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.474 2.31 . . . . 0.0 108.911 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.31 14.31 1.06 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.398 1.879 . . . . 0.0 114.94 -166.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' LYS . 2.3 pp -68.78 -23.4 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.4 t -82.5 111.51 18.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -93.06 39.24 1.04 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.594 1.958 . . . . 0.0 115.413 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.213 1.405 . . . . 0.0 114.423 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.64 -0.219 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 68.96 1.13 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.962 1.305 . . . . 0.0 109.939 168.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -73.68 62.7 0.81 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.019 1.728 . . . . 0.0 114.075 -170.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -134.34 67.75 1.5 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.483 2.713 . . . . 0.0 108.675 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.74 22.49 8.5 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.293 1.837 . . . . 0.0 115.938 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 17' ' ' VAL . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.89 -16.28 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -72.88 83.89 1.22 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.305 1.442 . . . . 0.0 110.924 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -75.3 -4.61 40.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.051 1.34 . . . . 0.0 113.793 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.4 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 128.03 2.532 . . . . 0.0 110.118 -179.238 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -79.16 53.48 1.47 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.049 1.34 . . . . 0.0 112.56 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER -79.68 40.73 0.46 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -176.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.4 mtp -133.79 87.21 2.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.497 2.319 . . . . 0.0 108.091 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 8.14 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -169.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.2 -21.8 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.9 m -72.23 96.02 1.76 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.345 1.058 . . . . 0.0 110.411 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -76.84 12.5 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.253 1.267 0 C-N-CA 127.316 2.246 . . . . 0.0 112.235 179.175 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.279 0.085 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.57 -179.12 7.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.418 1.487 . . . . 0.0 112.88 176.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -100.38 45.05 0.99 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.763 1.225 . . . . 0.0 111.626 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.0 mtm -130.12 88.0 2.59 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.433 1.111 . . . . 0.0 109.318 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.96 6.43 0.22 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.118 2.167 . . . . 0.0 116.0 -167.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -64.7 -31.45 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 m 37.61 37.65 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.635 2.774 . . . . 0.0 117.579 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' H ' HD12 ' A' ' 45' ' ' ILE 0.257 96.5 m-85 43.68 49.42 6.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.979 2.112 . . . . 0.0 114.64 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.257 1.459 0 C-N-CA 127.308 2.243 . . . . 0.0 113.662 177.255 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.78 173.77 4.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.371 1.068 . . . . 0.0 113.688 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB3' HE22 ' A' ' 8' ' ' GLN . 9.5 mptt -81.51 61.37 4.92 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.864 -1.148 . . . . 0.0 110.878 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 ptm -125.96 71.0 1.23 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.257 1.823 . . . . 0.0 109.941 -172.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.12 20.59 0.89 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.64 1.976 . . . . 0.0 115.6 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.59 -30.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m 33.57 37.72 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.574 3.15 . . . . 0.0 117.585 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 35.28 51.63 0.61 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.935 2.494 . . . . 0.0 114.686 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.804 2.042 . . . . 0.0 110.535 177.154 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -69.42 173.27 6.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.802 2.041 . . . . 0.0 115.28 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -73.39 39.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.731 2.012 . . . . 0.0 115.281 -177.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -115.04 77.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.477 1.911 . . . . 0.0 108.202 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 6.23 0.23 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -70.64 -15.4 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -66.74 106.44 1.85 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.801 174.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -84.75 -22.47 29.63 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.264 -0.898 . . . . 0.0 113.222 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.351 2.26 . . . . 0.0 114.046 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -72.08 161.15 31.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.25 1.42 . . . . 0.0 112.716 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -78.23 50.66 0.93 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.824 1.249 . . . . 0.0 111.872 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.3 mtt -115.58 68.53 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.349 2.259 . . . . 0.0 107.873 -169.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.32 -19.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.069 2.148 . . . . 0.0 115.087 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -20.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.9 m -75.08 45.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.023 1.729 . . . . 0.0 113.477 170.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -84.44 1.78 43.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.669 1.988 . . . . 0.0 114.299 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.023 0 C-N-CA 126.749 2.02 . . . . 0.0 113.148 -179.578 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 119.471 -0.3 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 51.51 -145.29 0.53 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.83 1.652 . . . . 0.0 113.126 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 147.62 8.99 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.95 67.31 0.74 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.386 1.875 . . . . 0.0 109.857 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.61 -14.33 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.988 2.515 . . . . 0.0 117.121 -172.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.39 -21.08 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m 38.78 49.37 1.49 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.803 2.841 . . . . 0.0 116.609 167.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 45.52 36.55 2.56 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 127.607 2.363 . . . . 0.0 115.604 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.256 1.414 0 C-N-CA 126.603 1.961 . . . . 0.0 112.966 178.559 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -78.67 150.49 32.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.476 1.11 . . . . 0.0 112.172 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -75.86 44.36 0.3 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.374 . . . . 0.0 114.642 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -135.25 101.01 4.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.382 1.473 . . . . 0.0 108.517 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.2 6.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -169.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' H ' HG12 ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -68.41 -32.06 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m 47.09 35.06 3.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.517 2.327 . . . . 0.0 116.766 168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' H ' HD12 ' A' ' 45' ' ' ILE . 71.7 m-85 39.27 53.51 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 114.843 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--O 1.256 1.433 0 C-N-CA 128.861 2.864 . . . . 0.0 110.558 178.772 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.023 0.44 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -74.9 63.35 1.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -172.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.01 48.2 0.7 Allowed 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.127 -1.608 . . . . 0.0 112.422 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -122.29 67.49 0.94 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.371 1.069 . . . . 0.0 110.32 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.07 31.79 6.93 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.947 1.299 . . . . 0.0 113.388 -167.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.64 ' H ' HG12 ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -27.54 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 p -77.82 27.67 0.17 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.854 2.061 . . . . 0.0 115.378 -170.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.45 -59.03 1.66 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.268 2.227 . . . . 0.0 110.099 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.951 1.3 . . . . 0.0 112.1 169.451 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 17' ' ' VAL . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 17' ' ' VAL . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' HG21 ' A' ' 17' ' ' VAL . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' HG21 ' A' ' 17' ' ' VAL . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 17' ' ' VAL . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 18' ' ' LYS . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' H ' HG12 ' A' ' 17' ' ' VAL . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HE3' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG12 ' HE3' ' A' ' 26' ' ' LYS . 2.7 pp . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB1' ' HA2' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.548 0.901 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA2' ' HB1' ' A' ' 5' ' ' ALA . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 35' ' ' HIS . 16.7 p80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.016 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.272 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' LYS . 2.3 pp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 17' ' ' VAL . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' H ' HG12 ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.929 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.64 ' H ' HG12 ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 7.7 p80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 119.737 -0.173 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -70.34 153.93 42.47 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.484 1.114 . . . . 0.0 113.49 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -86.63 44.93 1.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.48 -1.387 . . . . 0.0 112.608 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.9 ptp -139.91 109.26 6.17 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.147 1.779 . . . . 0.0 108.038 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.57 9.5 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 119.012 2.967 . . . . 0.0 119.012 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -115.46 -0.4 13.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.532 1.515 . . . . 0.0 114.275 170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -126.89 -18.93 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.78 22.72 14.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.192 2.197 . . . . 0.0 111.863 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 57.67 35.42 25.62 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.0 1.32 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.31 14.84 20.99 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.466 -1.186 . . . . 0.0 115.519 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.68 140.27 30.67 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.245 1.523 . . . . 0.0 108.346 -176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -152.96 176.06 12.27 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.93 28.22 4.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.544 1.537 . . . . 0.0 114.914 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 58.73 35.08 24.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.101 1.76 . . . . 0.0 114.531 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.81 152.38 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.797 1.639 . . . . 0.0 110.318 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -95.29 96.27 9.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 123.627 1.68 . . . . 0.0 106.794 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.78 154.83 40.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 112.302 -2.226 . . . . 0.0 112.011 -163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt 28.94 -66.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 134.029 4.932 . . . . 0.0 118.062 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.24 -13.81 81.34 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.67 -1.072 . . . . 0.0 113.022 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 55.3 101.08 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.696 2.798 . . . . 0.0 111.818 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -60.17 -31.27 69.95 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.494 -0.754 . . . . 0.0 111.547 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -40.06 -47.37 2.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.333 1.853 . . . . 0.0 113.292 167.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -73.68 -45.79 50.26 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.45 -33.76 75.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.218 1.007 . . . . 0.0 111.633 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -77.85 -28.8 50.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -30.2 71.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.926 1.693 . . . . 0.0 111.539 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.45 -40.57 75.03 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.035 0.834 . . . . 0.0 111.054 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.17 1.45 24.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.396 2.278 . . . . 0.0 113.53 175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 54.27 38.89 30.22 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.151 1.78 . . . . 0.0 112.847 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.709 2.004 . . . . 0.0 112.085 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -73.92 153.47 39.79 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 108.618 165.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.58 129.72 8.99 Favored Glycine 0 N--CA 1.47 0.928 0 CA-C-N 119.126 0.875 . . . . 0.0 112.157 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.27 130.96 70.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.059 1.743 . . . . 0.0 111.592 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.87 110.15 18.15 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -100.87 67.95 1.26 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.136 1.374 . . . . 0.0 112.453 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.76 -132.91 11.27 Favored Glycine 0 N--CA 1.471 1.016 0 C-N-CA 125.808 1.67 . . . . 0.0 110.848 -171.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.1 p -83.73 26.04 0.73 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.068 1.747 . . . . 0.0 112.053 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -129.85 143.8 50.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.794 2.038 . . . . 0.0 112.143 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -114.06 124.17 51.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.175 0.99 . . . . 0.0 112.405 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -134.4 172.27 13.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.801 1.641 . . . . 0.0 110.597 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.9 m -93.35 156.2 16.93 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.05 -84.3 1.79 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.888 1.232 . . . . 0.0 112.241 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.21 162.93 53.65 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 127.022 2.129 . . . . 0.0 110.87 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.77 141.74 43.75 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.184 3.256 . . . . 0.0 114.23 168.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.8 -13.79 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.771 1.228 . . . . 0.0 113.96 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 p -69.82 81.26 0.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.928 2.491 . . . . 0.0 110.289 168.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -77.83 3.88 13.23 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.268 2.227 . . . . 0.0 111.754 -173.475 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -76.01 167.47 21.82 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.883 2.073 . . . . 0.0 114.228 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.6 37.88 0.36 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.337 -1.477 . . . . 0.0 113.581 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 39.6 mtt -120.64 76.83 1.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.954 1.702 . . . . 0.0 109.094 -169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.5 25.03 1.25 Allowed 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -168.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.86 9.29 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.693 1.597 . . . . 0.0 114.524 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -134.28 -9.66 2.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.656 1.183 . . . . 0.0 113.376 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -110.26 34.77 3.72 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.834 2.054 . . . . 0.0 111.077 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 62.38 29.72 17.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.354 1.061 . . . . 0.0 112.49 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.23 -2.5 14.1 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.611 -1.66 . . . . 0.0 115.289 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.39 125.59 40.99 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.212 2.006 . . . . 0.0 111.106 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 17' ' ' VAL . 13.4 p90 -149.97 163.06 39.11 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.7 29.61 7.67 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.064 1.746 . . . . 0.0 114.341 -173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 59.64 26.26 15.3 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 17' ' ' VAL . 34.1 t -89.26 172.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.194 1.397 . . . . 0.0 110.187 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.77 103.05 12.24 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 169.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -125.42 5.27 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -154.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 30.5 mmtm 81.27 123.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.409 3.484 . . . . 0.0 114.521 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.24 -79.63 0.28 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -165.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 60.01 153.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.319 3.047 . . . . 0.0 115.144 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.26 -28.53 69.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.249 1.019 . . . . 0.0 112.873 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -37.94 -54.03 1.31 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.585 2.354 . . . . 0.0 112.936 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -67.81 -47.83 67.95 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.414 1.086 . . . . 0.0 113.199 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.06 -41.67 97.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.007 0.923 . . . . 0.0 111.866 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.6 m -70.51 -27.26 64.05 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.199 -0.938 . . . . 0.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -34.64 70.33 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.617 1.099 . . . . 0.0 111.069 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.02 -14.55 63.05 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.36 6.25 48.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.629 1.572 . . . . 0.0 111.266 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 t70 58.67 27.85 16.41 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.126 2.17 . . . . 0.0 113.184 -168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -113.74 157.64 21.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.789 1.636 . . . . 0.0 112.81 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -71.74 151.3 43.68 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.49 131.97 8.31 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 118.577 0.626 . . . . 0.0 112.234 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.72 139.88 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.927 1.691 . . . . 0.0 112.055 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.0 m -103.6 87.19 2.78 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.168 -0.958 . . . . 0.0 111.899 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -74.21 108.65 7.13 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.122 -0.986 . . . . 0.0 111.329 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.72 -120.14 21.59 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.3 p -94.89 9.59 38.68 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.029 1.732 . . . . 0.0 114.393 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -119.02 150.64 39.61 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.939 1.696 . . . . 0.0 113.612 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.0 123.95 47.57 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.803 1.241 . . . . 0.0 112.037 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.82 152.59 45.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.496 1.918 . . . . 0.0 109.997 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.9 m -87.91 160.37 17.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.039 0.923 . . . . 0.0 110.95 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.36 2.34 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.857 1.218 . . . . 0.0 110.832 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.8 m -131.87 170.2 11.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 127.236 2.215 . . . . 0.0 110.019 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.43 138.45 10.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.427 2.751 . . . . 0.0 112.937 167.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp -64.93 -27.55 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -58.17 123.37 15.76 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.402 0.62 . . . . 0.0 111.672 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.7 -15.43 40.31 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.365 1.066 . . . . 0.0 113.826 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.0 tp . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.668 2.787 . . . . 0.0 111.175 -175.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.94 161.84 28.16 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -171.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -94.8 76.8 3.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.818 2.047 . . . . 0.0 109.15 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 ptp -152.69 121.44 6.48 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.184 1.393 . . . . 0.0 107.668 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 47.48 13.57 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -167.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -123.27 1.26 9.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.754 2.022 . . . . 0.0 112.874 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.95 5.6 1.74 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.131 1.772 . . . . 0.0 115.19 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.65 29.79 3.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.44 2.296 . . . . 0.0 111.832 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 61.12 32.53 19.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.546 1.138 . . . . 0.0 113.196 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.98 5.25 25.1 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.506 -172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' HG21 ' A' ' 17' ' ' VAL . 23.8 t -108.48 119.65 40.13 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.947 1.699 . . . . 0.0 109.123 -170.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' HG21 ' A' ' 17' ' ' VAL . 17.9 p90 -146.7 168.2 21.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 112.51 -176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.06 30.82 3.05 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.667 1.987 . . . . 0.0 115.19 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.3 m120 49.63 35.7 9.2 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.813 1.645 . . . . 0.0 114.189 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.567 ' HB ' HG22 ' A' ' 17' ' ' VAL . 42.0 t -83.85 176.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.624 -1.298 . . . . 0.0 108.497 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -110.99 101.96 10.48 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 165.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -118.84 133.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 111.65 -2.523 . . . . 0.0 108.628 -160.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.325 1.0 OUTLIER -72.61 -1.86 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.308 2.707 . . . . 0.0 118.308 -162.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.64 -26.05 74.87 Favored Glycine 0 CA--C 1.541 1.694 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 163.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 44.37 99.27 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.633 2.773 . . . . 0.0 114.452 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -59.56 -23.8 63.19 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.438 -0.789 . . . . 0.0 112.457 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.91 -44.92 7.36 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 125.993 1.717 . . . . 0.0 111.383 168.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -64.76 -32.11 73.64 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -74.29 -43.75 55.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.904 0.882 . . . . 0.0 110.951 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.8 m -70.7 -25.02 62.77 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -28.16 69.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.161 1.384 . . . . 0.0 112.063 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.02 -24.62 59.04 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.8 9.97 26.73 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.836 2.054 . . . . 0.0 111.189 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 56.59 32.31 20.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.906 2.882 . . . . 0.0 115.001 -172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -109.09 157.87 18.3 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.744 1.217 . . . . 0.0 113.175 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.46 148.82 44.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.19 127.68 8.02 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 119.16 0.891 . . . . 0.0 111.348 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.09 121.48 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.2 p -79.39 96.92 6.15 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 166.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -79.19 27.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.224 1.41 . . . . 0.0 113.544 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.19 -135.38 5.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 129.704 3.526 . . . . 0.0 106.536 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -4.33 59.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 171.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -113.65 148.98 35.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.732 1.613 . . . . 0.0 110.074 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.39 142.24 39.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -131.72 164.66 25.47 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.802 2.441 . . . . 0.0 108.691 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -83.85 148.16 27.14 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.627 -0.671 . . . . 0.0 111.532 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.47 -88.38 1.26 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.176 1.37 . . . . 0.0 111.921 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.0 167.77 19.64 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.995 2.118 . . . . 0.0 110.323 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.3 135.46 38.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.865 3.043 . . . . 0.0 112.946 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.01 -26.19 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.2 m -35.92 110.09 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.658 1.983 . . . . 0.0 114.724 -167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -65.01 -39.16 93.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 112.129 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.262 1.825 . . . . 0.0 112.153 173.289 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -79.87 171.6 14.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 113.579 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 47.42 1.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.308 2.643 . . . . 0.0 112.186 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -119.22 73.4 0.94 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.802 2.041 . . . . 0.0 109.87 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.03 9.64 0.67 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.408 1.883 . . . . 0.0 115.255 -168.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.16 6.98 14.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.535 1.534 . . . . 0.0 113.338 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -133.09 -19.73 2.21 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.75 28.26 3.53 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.568 1.947 . . . . 0.0 112.308 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 60.79 31.44 20.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 111.429 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.26 7.38 25.13 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.399 -1.223 . . . . 0.0 115.666 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.14 129.94 34.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.554 1.677 . . . . 0.0 108.71 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -154.21 166.69 32.32 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.85 41.87 29.66 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.585 1.954 . . . . 0.0 113.668 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 60.77 17.39 7.61 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -95.16 150.8 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 120.487 -1.383 . . . . 0.0 110.905 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -101.95 81.13 2.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 18' ' ' LYS . 57.8 t -78.28 177.38 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 CA-C-N 109.779 -3.373 . . . . 0.0 109.051 -169.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' H ' HG12 ' A' ' 17' ' ' VAL . 73.0 mmtt -66.14 -3.65 6.0 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -169.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.0 -3.08 83.25 Favored Glycine 0 CA--C 1.546 1.974 0 C-N-CA 125.127 1.346 . . . . 0.0 113.976 167.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 54.11 91.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.929 2.891 . . . . 0.0 116.248 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.74 -34.65 77.63 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.177 -0.952 . . . . 0.0 110.743 169.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -46.23 -44.45 16.28 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.408 1.883 . . . . 0.0 112.744 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -84.35 -31.16 24.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.508 1.523 . . . . 0.0 114.267 -171.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -59.4 -51.27 70.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.788 0.722 . . . . 0.0 110.482 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.3 m -67.67 -27.38 66.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HE3' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -61.1 -29.19 69.61 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.969 -1.082 . . . . 0.0 113.001 176.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.55 -29.09 69.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.209 0.913 . . . . 0.0 111.762 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -92.63 9.22 35.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.748 2.019 . . . . 0.0 111.982 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.59 29.77 17.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.735 2.014 . . . . 0.0 113.85 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -111.76 161.67 16.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.679 1.991 . . . . 0.0 112.902 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.84 152.31 37.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.439 1.495 . . . . 0.0 108.943 167.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.99 119.97 2.14 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 118.872 0.76 . . . . 0.0 113.237 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.85 146.86 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.752 1.263 . . . . 0.0 111.531 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.5 t -84.27 118.94 24.5 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.058 -1.026 . . . . 0.0 110.737 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -89.19 87.48 7.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.481 1.512 . . . . 0.0 110.886 168.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.12 -106.84 1.84 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.525 1.059 . . . . 0.0 111.67 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.1 p -102.71 10.75 38.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.151 1.78 . . . . 0.0 114.112 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -122.55 148.18 45.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.659 1.984 . . . . 0.0 112.39 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.4 t -96.29 130.97 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.468 -0.77 . . . . 0.0 111.179 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.32 154.27 49.0 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 111.783 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 m -89.57 156.11 18.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.479 1.133 . . . . 0.0 113.846 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.75 -94.66 2.03 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.921 1.248 . . . . 0.0 111.382 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.97 168.64 16.76 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 127.591 2.356 . . . . 0.0 110.342 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -47.49 141.69 14.3 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.441 3.427 . . . . 0.0 113.928 168.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG12 ' HE3' ' A' ' 26' ' ' LYS . 2.7 pp -68.96 -15.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.054 0.942 . . . . 0.0 113.398 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -64.79 103.81 0.75 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.85 . . . . 0.0 110.724 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.54 22.02 1.99 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.596 1.158 . . . . 0.0 113.398 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.934 2.493 . . . . 0.0 112.089 176.197 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -172.92 4.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.267 1.827 . . . . 0.0 112.291 168.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.68 143.24 38.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 164.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.9 ptp -133.68 68.98 1.48 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.175 0.988 . . . . 0.0 109.64 -167.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB1' ' HA2' ' A' ' 10' ' ' GLY . . . 63.7 -16.16 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 128.441 2.697 . . . . 0.0 116.455 -173.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -92.4 13.05 20.65 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 122.063 2.21 . . . . 0.0 112.906 -170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 -2.34 7.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.367 1.467 . . . . 0.0 113.326 169.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.85 38.52 4.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.758 2.023 . . . . 0.0 110.328 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 62.79 16.5 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA2' ' HB1' ' A' ' 5' ' ' ALA . . . 69.84 33.41 70.69 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.586 -1.674 . . . . 0.0 114.206 -170.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t -144.48 124.07 13.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.647 1.979 . . . . 0.0 110.876 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.99 165.31 36.54 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.33 37.85 16.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.889 2.076 . . . . 0.0 115.676 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 61.83 24.64 14.7 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.095 1.758 . . . . 0.0 114.278 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -92.05 170.54 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.583 1.083 . . . . 0.0 109.047 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -113.05 66.89 0.65 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 126.08 2.848 . . . . 0.0 108.588 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -80.5 143.17 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 109.011 -3.722 . . . . 0.0 108.512 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -87.54 9.5 20.84 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -167.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.18 -28.58 65.99 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.37 -1.239 . . . . 0.0 113.234 169.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 52.37 118.48 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 128.34 2.656 . . . . 0.0 116.548 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -78.53 -7.32 57.38 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.705 -1.247 . . . . 0.0 112.49 168.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -41.21 -51.45 3.52 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 126.129 1.772 . . . . 0.0 111.988 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.3 mtm-85 -66.13 -44.13 85.13 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.931 1.242 . . . . 0.0 112.213 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -62.33 -42.62 99.53 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.362 1.465 . . . . 0.0 111.545 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.4 m -79.13 -27.32 42.81 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -65.11 -21.53 66.81 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.889 -1.132 . . . . 0.0 111.722 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.77 -21.64 63.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.745 1.218 . . . . 0.0 113.227 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -99.09 7.59 45.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.175 1.79 . . . . 0.0 112.769 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.354 1.1 p30 62.29 27.38 16.38 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.514 1.526 . . . . 0.0 114.017 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -120.48 165.64 14.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.25 154.28 27.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 110.032 164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.02 121.03 5.54 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.346 0.974 . . . . 0.0 111.605 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.8 133.17 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 123.491 1.615 . . . . 0.0 113.594 -174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.4 40.62 1.04 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -166.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.32 0.2 OUTLIER -73.94 39.31 0.11 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -170.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.95 -176.17 40.0 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.794 2.616 . . . . 0.0 111.058 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -69.8 -17.95 63.44 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 120.583 -1.539 . . . . 0.0 112.363 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -100.97 117.04 34.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.95 1.3 . . . . 0.0 108.975 168.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.25 145.55 28.26 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.15 0.58 . . . . 0.0 111.519 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.27 162.52 33.29 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.835 1.254 . . . . 0.0 111.322 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.6 m -84.2 154.76 22.87 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 112.798 170.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 -95.46 1.44 Allowed Glycine 0 CA--C 1.521 0.424 0 C-N-CA 124.926 1.25 . . . . 0.0 110.581 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.88 162.17 59.15 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.459 1.503 . . . . 0.0 110.905 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.82 137.28 43.07 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.941 3.094 . . . . 0.0 112.388 167.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.5 -20.89 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 112.394 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.1 m -66.53 117.23 8.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.561 1.144 . . . . 0.0 112.101 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.63 -1.08 25.05 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.585 1.154 . . . . 0.0 114.003 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.881 2.072 . . . . 0.0 110.31 179.688 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -75.4 176.61 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.786 1.634 . . . . 0.0 114.714 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -73.85 49.3 0.32 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.308 1.843 . . . . 0.0 113.718 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.5 ptp -113.57 61.24 0.65 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 110.683 -171.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.98 21.62 5.13 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.0 1.32 . . . . 0.0 113.894 -168.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -123.48 5.69 8.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.346 1.458 . . . . 0.0 113.86 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -136.17 -13.3 1.85 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.68 37.58 2.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.445 1.898 . . . . 0.0 111.502 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 61.91 26.21 15.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.675 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.95 -0.93 26.93 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.061 -1.411 . . . . 0.0 115.612 -173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 p -108.0 129.34 55.13 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.082 1.941 . . . . 0.0 112.097 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.34 173.55 14.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.897 -171.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.47 12.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.88 1.672 . . . . 0.0 113.919 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 56.27 50.82 12.62 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.492 1.917 . . . . 0.0 113.15 -172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.61 157.82 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.196 1.798 . . . . 0.0 109.214 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -108.21 63.2 0.61 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 124.704 2.192 . . . . 0.0 107.722 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.3 160.6 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 109.762 -3.381 . . . . 0.0 110.977 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -59.0 -10.81 2.77 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -167.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.03 -13.14 83.99 Favored Glycine 0 CA--C 1.543 1.836 0 C-N-CA 124.861 1.219 . . . . 0.0 114.139 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 41.39 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 129.131 2.972 . . . . 0.0 115.685 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.91 -25.48 66.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.438 -0.789 . . . . 0.0 113.089 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -41.1 -47.53 3.19 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.439 1.495 . . . . 0.0 110.999 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -61.47 -45.73 93.03 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.557 1.143 . . . . 0.0 112.821 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -59.7 -47.64 84.86 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.513 1.125 . . . . 0.0 111.578 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.66 -27.01 62.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -27.42 69.34 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.27 -1.519 . . . . 0.0 111.365 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.52 73.56 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.834 -1.166 . . . . 0.0 111.596 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -78.27 2.24 19.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.17 1.788 . . . . 0.0 113.117 169.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.18 29.65 13.88 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.936 1.694 . . . . 0.0 113.589 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.38 164.78 17.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.719 2.008 . . . . 0.0 114.315 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -75.87 157.14 33.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.823 1.249 . . . . 0.0 109.064 164.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.43 113.61 1.31 Allowed Glycine 0 N--CA 1.48 1.571 0 CA-C-N 120.663 1.574 . . . . 0.0 114.105 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 pp -109.26 120.6 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 123.043 1.402 . . . . 0.0 114.609 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.1 m -81.91 68.6 8.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.438 1.495 . . . . 0.0 113.143 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -70.92 109.5 5.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.6 1.191 . . . . 0.0 112.551 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.39 -116.65 6.73 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.378 0.989 . . . . 0.0 112.459 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -106.02 9.58 32.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.684 1.593 . . . . 0.0 113.445 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.92 169.16 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.116 2.166 . . . . 0.0 110.473 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.2 t -129.74 146.37 51.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.493 0.717 . . . . 0.0 112.263 166.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -142.24 151.41 42.07 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 128.477 2.711 . . . . 0.0 108.806 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -78.01 155.82 30.49 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.115 -0.991 . . . . 0.0 112.585 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.55 -98.78 1.28 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.35 1.452 . . . . 0.0 111.235 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.5 163.49 49.23 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 126.34 1.856 . . . . 0.0 110.591 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -49.71 134.04 33.55 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 124.135 3.223 . . . . 0.0 112.92 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.71 -15.25 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.829 0.852 . . . . 0.0 112.806 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -77.49 77.3 4.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 109.748 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -67.55 -20.51 65.41 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.042 0.937 . . . . 0.0 113.229 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.61 1.964 . . . . 0.0 113.506 -172.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -143.85 159.13 43.07 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 147.04 10.23 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.984 2.114 . . . . 0.0 115.521 -173.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 ptm -153.7 53.61 0.72 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.58 -15.4 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.439 2.296 . . . . 0.0 115.805 -169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.77 11.46 7.44 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 119.896 -1.752 . . . . 0.0 112.16 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -128.31 -3.61 5.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.703 2.401 . . . . 0.0 109.629 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.0 42.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.433 2.693 . . . . 0.0 110.85 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 62.49 30.73 17.22 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.8 16.73 56.94 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 117.924 -1.487 . . . . 0.0 114.34 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 t -131.0 122.77 27.42 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.568 1.684 . . . . 0.0 112.555 -166.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -161.81 173.01 15.18 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.02 35.51 26.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.802 2.041 . . . . 0.0 114.376 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.7 m120 51.54 40.55 27.24 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.688 1.195 . . . . 0.0 113.3 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 24.4 t -107.81 161.83 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.501 -1.375 . . . . 0.0 108.135 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -111.58 71.95 0.76 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 124.924 2.297 . . . . 0.0 105.538 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 13.4 t -70.94 160.95 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 109.17 -3.65 . . . . 0.0 110.885 -168.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.86 -17.19 64.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.44 -26.08 71.64 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.808 0.718 . . . . 0.0 113.877 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 47.15 99.64 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.071 2.548 . . . . 0.0 115.336 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 t -62.76 -21.06 65.57 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.204 -0.935 . . . . 0.0 112.817 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -39.7 -41.88 1.14 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.708 1.603 . . . . 0.0 111.814 167.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -72.31 -43.54 64.02 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.774 1.229 . . . . 0.0 113.484 -170.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -61.37 -44.14 97.68 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.307 1.043 . . . . 0.0 111.127 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.2 m -74.83 -26.05 59.43 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -24.7 67.52 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.447 -1.408 . . . . 0.0 112.147 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.3 -19.58 59.59 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.532 1.133 . . . . 0.0 113.748 170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -98.38 5.53 48.1 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.925 2.09 . . . . 0.0 111.947 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 63.14 18.21 10.77 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.501 1.92 . . . . 0.0 113.586 -168.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -112.96 163.32 14.81 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.453 1.501 . . . . 0.0 114.235 -173.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.43 156.06 31.38 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.042 1.337 . . . . 0.0 109.563 166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.65 113.16 2.02 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 119.722 1.146 . . . . 0.0 113.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.277 2.6 pp -117.94 125.4 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 122.953 1.359 . . . . 0.0 114.326 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 m -94.94 66.63 3.06 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.874 1.67 . . . . 0.0 110.436 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -67.41 30.94 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 128.259 2.624 . . . . 0.0 116.816 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.6 -124.31 1.56 Allowed Glycine 0 N--CA 1.464 0.522 0 C-N-CA 125.601 1.572 . . . . 0.0 109.178 -174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 p -104.37 6.34 35.05 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.408 1.083 . . . . 0.0 113.709 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -119.62 171.8 8.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.524 1.93 . . . . 0.0 110.687 170.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.7 t -123.06 151.17 42.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.509 1.147 . . . . 0.0 113.341 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 147.56 52.47 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.035 2.534 . . . . 0.0 108.381 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 69.8 m -79.79 139.27 37.31 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.008 167.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.73 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.326 0.965 . . . . 0.0 111.886 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.91 164.63 38.15 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.367 1.867 . . . . 0.0 110.696 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.49 130.99 22.79 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 124.168 3.246 . . . . 0.0 112.272 168.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.97 -22.8 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -83.28 122.92 29.08 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.634 0.652 . . . . 0.0 110.72 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -110.37 4.41 20.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.566 1.547 . . . . 0.0 114.56 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . 0.251 3.5 pp . . . . . 0 C--O 1.253 1.244 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -141.52 -177.57 5.22 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 53.44 0.19 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.85 2.46 . . . . 0.0 116.309 -169.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.5 ptm -117.13 62.35 0.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.832 2.053 . . . . 0.0 109.588 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.4 24.09 9.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.871 1.669 . . . . 0.0 114.197 -167.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -125.07 8.64 8.01 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.539 1.536 . . . . 0.0 114.388 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -131.83 -28.87 1.75 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.101 1.36 . . . . 0.0 112.454 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.71 35.93 0.79 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.345 1.458 . . . . 0.0 111.567 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 62.92 4.37 1.47 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.462 1.505 . . . . 0.0 114.528 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.8 15.67 72.36 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.944 1.259 . . . . 0.0 115.328 -169.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -105.57 137.95 42.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.465 1.632 . . . . 0.0 110.483 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.72 174.2 14.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.81 22.04 1.6 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.339 2.256 . . . . 0.0 116.252 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.64 53.51 10.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.401 1.48 . . . . 0.0 111.433 -167.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 21.6 t -113.11 158.57 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.514 1.526 . . . . 0.0 107.161 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -108.83 47.14 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 125.475 2.559 . . . . 0.0 109.655 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.5 t -47.52 155.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 1 C-N-CA 132.284 4.233 . . . . 0.0 111.642 176.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -64.54 -26.87 68.61 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.41 -1.432 . . . . 0.0 112.896 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.35 77.16 0.89 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 166.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.95 152.31 45.43 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.9 t -101.44 -20.66 15.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.18 0.992 . . . . 0.0 112.851 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -38.41 -50.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.138 1.775 . . . . 0.0 112.219 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -65.35 -32.49 74.17 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -71.26 -48.11 52.95 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.681 0.793 . . . . 0.0 110.613 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.5 m -71.94 -27.4 62.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -59.15 -28.85 66.96 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.081 -1.012 . . . . 0.0 112.278 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.37 -25.12 64.92 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 9.44 29.78 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.684 1.194 . . . . 0.0 112.3 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.44 35.81 24.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.969 2.108 . . . . 0.0 112.863 -170.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -120.59 162.67 19.25 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 127.157 2.183 . . . . 0.0 113.446 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -79.87 153.29 29.15 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.172 0.989 . . . . 0.0 109.275 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.61 116.06 3.57 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-O 118.412 -1.215 . . . . 0.0 113.131 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.25 2.5 pp -115.98 120.86 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.05 79.92 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 111.293 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.426 ' CD2' ' H ' ' A' ' 35' ' ' HIS . 16.7 p80 -68.79 10.41 0.28 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -174.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.95 -134.11 3.45 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.42 1.486 . . . . 0.0 109.401 -175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 3.0 23.33 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 119.129 1.464 . . . . 0.0 113.996 168.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -119.51 164.31 15.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.112 1.765 . . . . 0.0 112.119 171.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.36 140.32 52.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.039 0.936 . . . . 0.0 113.061 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -130.44 155.04 47.08 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.868 2.467 . . . . 0.0 108.694 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.7 148.11 33.22 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.212 -0.93 . . . . 0.0 112.334 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.56 -81.25 1.38 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.142 0.877 . . . . 0.0 112.428 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.03 162.67 44.58 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.891 1.676 . . . . 0.0 111.318 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.4 131.99 48.38 Favored 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 124.379 3.386 . . . . 0.0 111.782 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.67 -32.59 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -169.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.9 m -60.32 112.58 1.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -83.64 -18.41 38.2 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.636 1.575 . . . . 0.0 112.324 179.633 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 174.44 3.49 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -112.25 43.78 1.54 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -143.02 112.22 6.65 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.598 1.159 . . . . 0.0 109.337 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 50.9 10.19 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.787 2.435 . . . . 0.0 115.59 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -112.65 -4.01 14.18 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.517 1.527 . . . . 0.0 113.867 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -144.48 6.29 1.26 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.38 21.22 4.77 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.345 1.458 . . . . 0.0 111.442 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 61.1 33.88 19.3 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.665 1.186 . . . . 0.0 110.828 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 3.71 19.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.976 1.274 . . . . 0.0 114.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.0 119.71 33.98 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.728 1.611 . . . . 0.0 110.844 -169.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -148.68 177.74 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.467 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.24 32.74 2.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.407 1.483 . . . . 0.0 113.956 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.33 16.19 8.3 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 127.269 2.228 . . . . 0.0 116.67 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 16' ' ' ASP . 3.2 t -83.46 -169.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 119.482 1.037 . . . . 0.0 109.779 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 15' ' ' VAL . 12.9 t70 -126.39 107.95 10.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t -123.19 154.43 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.168 -161.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -30.89 -44.82 0.06 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 130.831 3.652 . . . . 0.0 118.709 -167.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.87 -8.56 87.28 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.111 0.862 . . . . 0.0 114.707 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 52.38 108.4 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.607 2.763 . . . . 0.0 116.986 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.3 t -64.15 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 166.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -44.78 -48.4 10.89 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.098 1.759 . . . . 0.0 112.831 169.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -70.97 -44.11 66.7 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.809 1.186 . . . . 0.0 113.493 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -35.13 78.8 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.198 0.454 . . . . 0.0 111.813 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.51 -36.5 63.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 171.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.21 -35.07 74.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.654 1.182 . . . . 0.0 112.295 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.74 -24.35 67.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.242 1.017 . . . . 0.0 112.957 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -98.1 11.4 37.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.257 2.223 . . . . 0.0 112.08 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.342 1.2 p30 64.78 15.83 10.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 128.95 2.9 . . . . 0.0 116.755 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -108.75 160.17 16.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.412 1.485 . . . . 0.0 114.273 -176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.96 154.17 33.84 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.087 -1.008 . . . . 0.0 108.336 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.86 127.73 5.47 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.081 0.855 . . . . 0.0 112.463 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.47 141.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.552 1.541 . . . . 0.0 110.938 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.41 116.75 29.26 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.37 -0.831 . . . . 0.0 111.09 -168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -97.28 111.37 23.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.818 1.247 . . . . 0.0 112.285 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.15 -124.27 33.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.816 -0.552 . . . . 0.0 111.795 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.1 p -91.66 9.78 30.93 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.605 1.562 . . . . 0.0 113.829 172.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -121.04 157.96 28.86 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.674 1.59 . . . . 0.0 111.992 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.5 t -97.63 147.33 24.42 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.543 0.737 . . . . 0.0 111.02 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -141.86 145.5 34.7 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.23 1.412 . . . . 0.0 109.419 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.1 m -83.38 156.9 22.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.196 0.907 . . . . 0.0 111.709 168.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.76 -101.87 2.39 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.245 1.403 . . . . 0.0 110.296 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.51 166.58 20.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.124 2.17 . . . . 0.0 110.81 -173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.85 134.41 54.61 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.44 2.76 . . . . 0.0 112.393 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.79 -19.75 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.341 1.057 . . . . 0.0 113.051 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -84.84 76.01 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.575 1.55 . . . . 0.0 109.951 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -56.84 -35.9 69.38 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.08 2.552 . . . . 0.0 110.636 178.26 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.65 52.65 1.94 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -169.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 43.32 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.804 1.642 . . . . 0.0 113.821 173.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.8 mtt -131.88 70.11 1.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.989 2.915 . . . . 0.0 107.24 -168.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 54.25 24.77 5.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.142 2.177 . . . . 0.0 116.138 -169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -125.95 10.57 7.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.679 1.192 . . . . 0.0 113.655 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -127.89 -26.09 2.97 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.077 1.751 . . . . 0.0 113.771 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.99 33.9 1.63 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.127 1.771 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 62.96 15.67 8.56 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -7.12 82.68 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 115.802 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 120.137 1.969 . . . . 0.0 110.234 -169.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.37 170.55 21.98 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 173.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.89 37.77 21.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.443 1.897 . . . . 0.0 114.421 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.3 m120 56.36 42.26 27.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.502 -173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 2.5 t -130.73 159.99 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.193 1.397 . . . . 0.0 108.563 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.02 117.44 33.53 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.1 t -143.78 156.11 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.046 -162.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.34 0.0 OUTLIER 1.07 69.63 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 131.096 3.758 . . . . 0.0 116.934 -169.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.59 2.57 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.412 1.482 . . . . 0.0 113.272 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . 0.342 3.8 p-10 55.83 143.93 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.719 3.208 . . . . 0.0 118.893 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -74.42 -30.76 62.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.931 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -47.45 -53.59 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.709 1.203 . . . . 0.0 111.81 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -65.65 -33.59 76.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -63.85 -52.4 60.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.07 0.85 . . . . 0.0 110.81 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.0 m -68.85 -26.36 65.11 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.526 -0.733 . . . . 0.0 112.88 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -24.62 61.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.126 0.97 . . . . 0.0 112.394 172.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.21 65.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.136 0.88 . . . . 0.0 112.952 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -95.03 10.07 37.1 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.878 1.671 . . . . 0.0 112.475 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t70 56.81 30.29 17.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.738 2.415 . . . . 0.0 114.651 -171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.77 161.33 15.21 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.534 1.534 . . . . 0.0 112.073 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.46 149.93 43.76 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 164.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.02 134.48 9.54 Favored Glycine 0 N--CA 1.466 0.672 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.86 146.99 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 125.271 1.428 . . . . 0.0 109.804 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -86.66 123.93 32.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.499 -0.75 . . . . 0.0 111.027 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -98.51 102.2 13.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.779 1.632 . . . . 0.0 109.734 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -120.92 24.81 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.257 -0.902 . . . . 0.0 111.495 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.76 13.15 15.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 128.048 2.539 . . . . 0.0 114.537 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -130.17 143.33 50.72 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.607 1.563 . . . . 0.0 112.967 -170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 32.8 t -88.66 132.22 34.66 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.509 -0.744 . . . . 0.0 111.167 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -131.85 150.93 52.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.864 1.265 . . . . 0.0 110.042 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.3 m -83.69 156.0 22.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.824 0.821 . . . . 0.0 112.232 169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.37 -91.5 1.89 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.62 1.105 . . . . 0.0 111.383 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.48 165.79 33.59 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.825 2.45 . . . . 0.0 110.803 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.85 134.83 49.27 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.724 2.95 . . . . 0.0 110.153 165.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 pp -65.08 -18.16 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 m -72.81 88.58 1.33 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.188 1.395 . . . . 0.0 110.54 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -69.57 -27.57 65.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.458 1.103 . . . . 0.0 112.519 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.303 1.841 . . . . 0.0 109.573 169.81 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -79.17 166.4 22.26 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.325 1.45 . . . . 0.0 112.771 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -77.16 54.15 1.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.527 -1.358 . . . . 0.0 112.331 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtp -124.68 69.22 1.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.474 2.31 . . . . 0.0 108.911 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.31 14.31 1.06 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.398 1.879 . . . . 0.0 114.94 -166.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -117.27 10.88 13.87 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.549 1.94 . . . . 0.0 113.193 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.99 1.84 1.49 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.549 1.54 . . . . 0.0 112.842 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.83 37.36 4.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.332 2.253 . . . . 0.0 110.803 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 62.01 22.02 12.78 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.708 1.203 . . . . 0.0 113.06 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.88 17.7 67.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 117.41 -1.772 . . . . 0.0 115.172 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -116.51 125.37 51.82 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.76 1.78 . . . . 0.0 110.932 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.99 174.98 14.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.242 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.45 27.18 3.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.708 2.003 . . . . 0.0 115.822 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 58.9 33.98 23.37 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.89 1.676 . . . . 0.0 114.476 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 18.5 t -100.72 176.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.151 -0.968 . . . . 0.0 110.198 -175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' N ' HG12 ' A' ' 15' ' ' VAL . 27.5 t70 -109.67 106.59 16.31 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 167.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.3 t -125.11 146.66 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.197 -162.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.44 -31.46 9.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.54 -12.44 83.71 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 32.12 115.04 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 131.554 3.941 . . . . 0.0 118.275 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 55.8 m -58.04 -26.01 61.91 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.477 -1.389 . . . . 0.0 113.298 168.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -36.88 -54.16 0.93 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.642 1.977 . . . . 0.0 112.283 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -77.09 -33.78 56.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.108 0.963 . . . . 0.0 113.372 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -63.3 -48.23 78.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.112 0.965 . . . . 0.0 111.75 169.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 m -73.21 -23.24 60.37 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -62.7 -29.14 70.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.884 -1.135 . . . . 0.0 112.396 178.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.54 72.51 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.764 0.826 . . . . 0.0 113.052 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -88.82 5.06 45.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.767 2.027 . . . . 0.0 111.685 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.26 13.0 t70 59.33 34.13 22.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.963 2.505 . . . . 0.0 113.819 -174.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -118.8 161.47 20.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.497 1.919 . . . . 0.0 113.111 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -73.19 155.64 39.39 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 164.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.66 131.65 9.27 Favored Glycine 0 N--CA 1.471 0.997 0 CA-C-N 119.357 0.981 . . . . 0.0 111.728 172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.41 141.96 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.045 1.338 . . . . 0.0 110.928 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 m -96.73 113.89 25.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.713 0.768 . . . . 0.0 110.808 -167.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -98.72 101.59 13.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.175 1.79 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.21 -127.46 24.16 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -96.31 19.11 12.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.381 1.072 . . . . 0.0 112.28 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -116.11 152.26 34.0 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 111.985 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 23.4 t -99.67 132.3 45.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.128 0.971 . . . . 0.0 111.651 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -134.59 164.61 27.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.11 156.39 16.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.753 0.787 . . . . 0.0 111.557 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.85 -88.08 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.71 1.147 . . . . 0.0 111.442 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.65 159.56 71.97 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 125.059 1.344 . . . . 0.0 111.658 -175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.32 136.68 69.76 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.281 2.654 . . . . 0.0 110.3 169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG21 ' HE3' ' A' ' 26' ' ' LYS . 2.3 pp -68.78 -23.4 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -171.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.4 t -82.5 111.51 18.58 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -93.06 39.24 1.04 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.594 1.958 . . . . 0.0 115.413 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.213 1.405 . . . . 0.0 114.423 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.64 -0.219 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.63 68.96 1.13 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.962 1.305 . . . . 0.0 109.939 168.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -73.68 62.7 0.81 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.019 1.728 . . . . 0.0 114.075 -170.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -134.34 67.75 1.5 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.483 2.713 . . . . 0.0 108.675 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.74 22.49 8.5 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.293 1.837 . . . . 0.0 115.938 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -117.43 3.17 12.5 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -133.25 -3.65 3.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.765 1.626 . . . . 0.0 113.432 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.37 35.08 4.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.232 2.213 . . . . 0.0 111.044 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 61.37 31.46 19.2 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.394 -0.816 . . . . 0.0 112.74 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.06 0.98 8.16 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.393 -1.782 . . . . 0.0 116.144 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.5 p -110.08 124.05 50.8 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 120.812 2.306 . . . . 0.0 111.378 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -145.58 167.28 23.42 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 48.51 37.63 9.43 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.954 1.702 . . . . 0.0 114.01 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m120 55.03 27.69 9.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.88 1.272 . . . . 0.0 114.39 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 17' ' ' VAL . 23.7 t -85.44 171.01 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.234 1.379 . . . . 0.0 109.061 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -107.02 106.48 17.02 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -130.72 127.45 61.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 112.36 -2.2 . . . . 0.0 108.31 -161.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.285 8.4 mmpt? -66.96 3.01 1.19 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 118.402 2.742 . . . . 0.0 118.402 -163.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.98 -20.27 70.6 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 162.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 43.93 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.878 2.871 . . . . 0.0 114.736 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 t -59.02 -22.4 60.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -40.73 -46.17 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.149 1.38 . . . . 0.0 111.073 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -66.66 -45.08 80.1 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.413 1.085 . . . . 0.0 113.188 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -59.97 -49.26 78.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.875 1.27 . . . . 0.0 111.087 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.8 m -68.52 -29.82 68.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.705 -0.665 . . . . 0.0 112.751 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -30.52 71.22 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.012 1.278 . . . . 0.0 111.353 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.38 71.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.994 0.815 . . . . 0.0 112.409 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.42 4.57 23.62 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.886 1.674 . . . . 0.0 111.428 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.251 7.7 t70 65.47 39.29 5.19 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.719 2.808 . . . . 0.0 115.02 -176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -135.68 171.6 14.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.99 156.03 30.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.359 1.464 . . . . 0.0 109.506 164.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.61 7.88 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.182 0.901 . . . . 0.0 112.696 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.35 116.96 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 123.108 1.433 . . . . 0.0 114.026 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -84.35 88.11 7.24 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.945 1.298 . . . . 0.0 110.952 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -84.85 10.33 11.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -170.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.64 -132.5 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.932 1.729 . . . . 0.0 110.393 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -2.37 44.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.653 1.981 . . . . 0.0 112.479 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.05 164.92 19.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.738 2.815 . . . . 0.0 111.16 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -120.03 159.79 24.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.967 1.307 . . . . 0.0 112.694 172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -138.12 158.37 44.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.259 2.223 . . . . 0.0 109.597 167.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.6 m -80.93 155.3 26.56 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.78 0.8 . . . . 0.0 112.174 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.29 -95.69 1.71 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.547 1.546 . . . . 0.0 111.993 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.72 164.34 44.75 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.171 1.788 . . . . 0.0 111.024 -175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.88 146.35 29.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.572 3.515 . . . . 0.0 114.718 170.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.89 -16.28 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 m -72.88 83.89 1.22 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.305 1.442 . . . . 0.0 110.924 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -75.3 -4.61 40.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.051 1.34 . . . . 0.0 113.793 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.4 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 128.03 2.532 . . . . 0.0 110.118 -179.238 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -79.16 53.48 1.47 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.049 1.34 . . . . 0.0 112.56 -175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.37 0.0 OUTLIER -79.68 40.73 0.46 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -176.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.4 mtp -133.79 87.21 2.35 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.497 2.319 . . . . 0.0 108.091 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 8.14 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -169.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -120.5 13.27 11.73 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.927 1.691 . . . . 0.0 113.145 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -138.4 -34.99 0.62 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.886 1.274 . . . . 0.0 111.459 167.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.56 40.16 0.77 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 113.045 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.35 11.25 1.56 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.115 1.366 . . . . 0.0 114.476 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 5.43 89.05 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 117.986 -1.452 . . . . 0.0 115.638 -170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.8 p -110.72 135.09 51.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 120.452 2.126 . . . . 0.0 112.386 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -153.8 173.6 15.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.006 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.18 35.38 13.2 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.83 1.652 . . . . 0.0 114.628 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.269 0.1 OUTLIER 54.26 27.75 8.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.425 1.89 . . . . 0.0 114.405 -171.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 19.3 t -95.28 156.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.668 -1.27 . . . . 0.0 108.702 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -106.23 60.29 0.65 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 125.057 2.36 . . . . 0.0 108.126 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 3.5 t -60.77 159.82 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 109.772 -3.376 . . . . 0.0 110.907 -172.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -51.74 -22.55 3.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -168.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.86 -11.34 36.69 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-N 120.298 1.408 . . . . 0.0 115.482 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 44.28 82.26 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.138 2.575 . . . . 0.0 114.113 174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.44 -23.61 62.82 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.259 -0.901 . . . . 0.0 113.294 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -39.05 -41.28 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.593 2.357 . . . . 0.0 112.368 166.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -71.54 -40.53 69.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.281 1.832 . . . . 0.0 113.811 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -60.26 -49.95 75.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.288 0.635 . . . . 0.0 110.661 172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.47 -25.02 61.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -30.71 63.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.739 -1.226 . . . . 0.0 112.395 170.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.33 -24.38 67.83 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.064 0.847 . . . . 0.0 113.25 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -107.73 12.19 27.65 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.993 1.717 . . . . 0.0 112.442 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.46 41.11 31.26 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.465 1.906 . . . . 0.0 113.753 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.37 163.83 17.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.345 1.858 . . . . 0.0 113.483 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.55 151.01 30.94 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.217 1.407 . . . . 0.0 109.032 166.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.53 123.58 7.26 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.224 0.916 . . . . 0.0 111.829 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.3 107.69 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 123.942 1.83 . . . . 0.0 112.818 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.44 92.21 2.32 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 169.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -87.03 5.15 38.91 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -168.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.04 -126.42 1.32 Allowed Glycine 0 N--CA 1.465 0.632 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.6 p -82.36 -0.7 47.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.409 1.605 . . . . 0.0 114.141 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -123.51 164.79 18.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.157 2.183 . . . . 0.0 111.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.9 t -121.64 148.9 43.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.262 1.025 . . . . 0.0 112.832 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -136.42 172.45 12.99 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.876 2.07 . . . . 0.0 109.338 170.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.6 m -84.55 152.21 24.04 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.124 -0.985 . . . . 0.0 112.577 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.98 -94.78 1.57 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.817 1.199 . . . . 0.0 110.733 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.81 164.85 35.85 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.556 1.942 . . . . 0.0 111.648 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.23 136.45 46.32 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 124.175 3.25 . . . . 0.0 110.883 166.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.2 -21.8 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.542 0.61 . . . . 0.0 112.494 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 72.9 m -72.23 96.02 1.76 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.345 1.058 . . . . 0.0 110.411 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -76.84 12.5 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.253 1.267 0 C-N-CA 127.316 2.246 . . . . 0.0 112.235 179.175 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.279 0.085 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.57 -179.12 7.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.418 1.487 . . . . 0.0 112.88 176.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -100.38 45.05 0.99 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.763 1.225 . . . . 0.0 111.626 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.0 mtm -130.12 88.0 2.59 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.433 1.111 . . . . 0.0 109.318 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.96 6.43 0.22 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 127.118 2.167 . . . . 0.0 116.0 -167.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -108.14 3.44 23.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.272 1.429 . . . . 0.0 114.013 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -130.71 -29.76 1.9 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 30.73 1.91 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.201 1.801 . . . . 0.0 111.67 -172.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 60.67 26.36 16.11 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.395 -0.816 . . . . 0.0 112.21 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.86 -2.48 17.17 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 117.687 -1.619 . . . . 0.0 116.054 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.5 p -98.17 128.25 44.55 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.601 2.201 . . . . 0.0 112.019 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.93 173.89 13.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.637 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.72 32.99 7.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.236 1.815 . . . . 0.0 114.182 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.279 9.2 t-20 49.96 49.46 20.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.248 1.819 . . . . 0.0 115.173 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.18 154.78 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.076 1.751 . . . . 0.0 107.895 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -105.92 61.32 0.66 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 125.208 2.432 . . . . 0.0 107.404 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.71 153.44 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 109.364 -3.562 . . . . 0.0 110.449 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -61.91 -8.85 5.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 117.897 2.555 . . . . 0.0 117.897 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -19.05 73.82 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 120.562 1.528 . . . . 0.0 114.303 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 52.34 106.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 129.404 3.082 . . . . 0.0 117.736 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -73.26 -28.7 62.28 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.907 0.883 . . . . 0.0 112.264 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.77 -47.33 4.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.512 1.525 . . . . 0.0 111.706 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -65.04 -34.51 78.61 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -47.18 60.59 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.597 0.759 . . . . 0.0 110.899 173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.6 m -69.24 -28.24 66.16 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.15 -27.57 68.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.978 1.311 . . . . 0.0 112.785 175.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.21 -19.85 65.95 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.128 0.876 . . . . 0.0 113.129 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -102.62 4.82 38.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.896 2.078 . . . . 0.0 112.531 174.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 t70 58.69 36.52 24.99 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.169 2.188 . . . . 0.0 112.954 -168.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.13 157.25 23.86 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.348 1.859 . . . . 0.0 113.608 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -75.4 149.87 38.5 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.413 1.085 . . . . 0.0 109.055 167.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.63 104.42 1.1 Allowed Glycine 0 N--CA 1.468 0.818 0 C-N-CA 124.728 1.156 . . . . 0.0 111.828 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.259 2.5 pp -106.39 114.33 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 123.386 1.565 . . . . 0.0 112.821 -173.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -80.64 66.46 6.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.697 1.199 . . . . 0.0 111.669 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -64.12 14.37 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.79 -121.9 1.0 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -92.04 -7.14 49.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.713 1.205 . . . . 0.0 113.714 169.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -120.3 164.22 16.63 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.814 2.046 . . . . 0.0 111.396 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.2 t -120.88 140.59 51.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.855 1.312 . . . . 0.0 114.236 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -131.39 147.73 52.59 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.02 2.528 . . . . 0.0 108.999 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.0 m -77.36 143.56 38.64 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.34 0.973 . . . . 0.0 111.551 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.85 -94.71 0.97 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.17 167.53 21.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.525 1.93 . . . . 0.0 110.384 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.98 133.73 23.32 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.1 3.2 . . . . 0.0 112.191 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -64.7 -31.45 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -172.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 m 37.61 37.65 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.635 2.774 . . . . 0.0 117.579 169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' H ' HD12 ' A' ' 45' ' ' ILE 0.257 96.5 m-85 43.68 49.42 6.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.979 2.112 . . . . 0.0 114.64 -178.347 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.257 1.459 0 C-N-CA 127.308 2.243 . . . . 0.0 113.662 177.255 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.78 173.77 4.95 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.371 1.068 . . . . 0.0 113.688 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB3' HE22 ' A' ' 8' ' ' GLN . 9.5 mptt -81.51 61.37 4.92 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.864 -1.148 . . . . 0.0 110.878 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 ptm -125.96 71.0 1.23 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.257 1.823 . . . . 0.0 109.941 -172.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.12 20.59 0.89 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.64 1.976 . . . . 0.0 115.6 -169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -124.97 10.02 8.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.755 1.222 . . . . 0.0 113.774 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -131.64 -21.25 2.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.205 1.402 . . . . 0.0 113.183 172.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -110.19 39.42 2.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.87 2.068 . . . . 0.0 111.761 -170.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 59.57 27.72 16.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.643 0.777 . . . . 0.0 112.956 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.0 11.91 46.76 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 117.236 -1.869 . . . . 0.0 115.679 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -107.72 126.63 52.85 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.92 2.36 . . . . 0.0 111.968 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -162.19 171.43 17.41 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.49 38.59 30.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.409 1.884 . . . . 0.0 113.218 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 54.56 50.55 15.76 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.495 1.518 . . . . 0.0 113.007 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -134.7 147.17 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -104.84 64.19 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 125.153 2.406 . . . . 0.0 105.187 171.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.9 t -52.49 155.59 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 109.331 -3.577 . . . . 0.0 109.185 176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' N ' ' HE2' ' A' ' 18' ' ' LYS 0.331 4.2 mmpt? -65.35 6.8 0.25 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 118.83 2.9 . . . . 0.0 118.83 -164.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.28 -22.43 78.55 Favored Glycine 0 CA--C 1.548 2.151 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 162.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 58.69 105.04 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 131.523 3.929 . . . . 0.0 118.379 168.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 38.8 t -68.74 -34.19 75.19 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 166.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -46.73 -53.04 12.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.063 1.745 . . . . 0.0 113.0 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -67.7 -39.82 84.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.961 1.304 . . . . 0.0 114.084 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -60.85 -47.78 84.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.717 0.407 . . . . 0.0 110.668 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.77 -26.59 62.5 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -59.22 -29.43 67.5 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.842 1.201 . . . . 0.0 112.823 176.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.8 62.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.124 0.97 . . . . 0.0 113.3 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -89.15 2.56 53.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.06 1.344 . . . . 0.0 111.642 168.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.1 t70 59.32 32.5 21.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.435 1.894 . . . . 0.0 114.03 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -115.74 160.47 20.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.947 1.299 . . . . 0.0 112.99 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -73.53 162.06 29.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 109.442 167.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.61 123.04 2.27 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.735 1.152 . . . . 0.0 113.455 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -123.65 142.9 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.582 1.553 . . . . 0.0 112.891 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 59.0 m -102.54 91.55 4.27 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.139 0.975 . . . . 0.0 110.88 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -87.12 111.31 20.8 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.385 1.088 . . . . 0.0 111.096 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.96 -116.24 6.23 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.951 1.263 . . . . 0.0 111.225 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.3 p -105.86 17.61 23.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.294 1.838 . . . . 0.0 113.232 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -126.01 135.59 51.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.749 1.62 . . . . 0.0 112.594 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.5 t -86.21 136.97 32.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.272 1.029 . . . . 0.0 110.087 169.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.18 144.73 47.15 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.855 1.262 . . . . 0.0 110.453 171.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 43.5 m -77.29 159.4 29.61 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.942 166.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.44 -100.81 2.29 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.28 167.4 22.63 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 127.382 2.273 . . . . 0.0 109.629 -171.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.44 138.05 24.56 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 123.786 2.991 . . . . 0.0 112.621 169.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.59 -30.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 118.469 -0.777 . . . . 0.0 113.054 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m 33.57 37.72 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.574 3.15 . . . . 0.0 117.585 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 35.28 51.63 0.61 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.935 2.494 . . . . 0.0 114.686 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.804 2.042 . . . . 0.0 110.535 177.154 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -69.42 173.27 6.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.802 2.041 . . . . 0.0 115.28 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -73.39 39.32 0.1 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.731 2.012 . . . . 0.0 115.281 -177.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -115.04 77.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.477 1.911 . . . . 0.0 108.202 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.17 6.23 0.23 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -115.2 8.07 15.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.78 1.173 . . . . 0.0 113.182 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -130.61 5.13 4.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.69 28.59 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.271 2.228 . . . . 0.0 110.666 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 63.47 5.68 2.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.615 1.166 . . . . 0.0 113.829 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.34 31.49 63.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.903 -168.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -134.12 139.19 45.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.958 2.103 . . . . 0.0 112.18 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.51 -178.97 7.17 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.611 -0.681 . . . . 0.0 112.668 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.17 35.34 16.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.114 1.365 . . . . 0.0 114.509 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 59.81 25.24 14.28 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 127.44 2.296 . . . . 0.0 115.257 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 20.4 t -102.26 157.75 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.189 1.359 . . . . 0.0 109.421 -177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -104.19 56.86 0.72 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 125.379 2.514 . . . . 0.0 108.64 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 14.8 t -53.8 156.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 109.915 -3.311 . . . . 0.0 110.94 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -61.48 -8.11 3.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.807 2.043 . . . . 0.0 115.86 -169.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.81 -17.08 66.88 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-N 119.347 0.976 . . . . 0.0 113.584 168.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 48.59 86.77 0.02 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.313 2.245 . . . . 0.0 114.287 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.28 -20.49 43.05 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -38.41 -45.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.117 1.767 . . . . 0.0 111.267 167.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -68.95 -31.6 70.59 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -73.04 -48.12 38.88 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.059 0.943 . . . . 0.0 110.75 171.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 m -72.81 -19.56 61.31 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.26 -0.9 . . . . 0.0 113.032 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -33.47 68.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.723 1.609 . . . . 0.0 111.973 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.18 -26.23 67.57 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.59 0.756 . . . . 0.0 113.019 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.88 2.35 43.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.343 1.857 . . . . 0.0 112.638 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.257 9.4 t70 56.86 31.7 20.1 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.043 2.537 . . . . 0.0 114.26 -169.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -112.76 161.59 16.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.424 1.49 . . . . 0.0 113.438 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -70.26 148.73 48.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.698 1.199 . . . . 0.0 109.381 167.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.45 109.95 2.16 Favored Glycine 0 N--CA 1.47 0.946 0 C-N-CA 124.849 1.214 . . . . 0.0 112.798 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.273 2.5 pp -116.73 115.11 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 123.403 1.573 . . . . 0.0 112.899 -173.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.04 86.79 7.17 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.96 -1.088 . . . . 0.0 111.477 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -85.25 62.13 7.3 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.232 1.015 . . . . 0.0 110.427 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.51 -173.44 27.23 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.057 1.789 . . . . 0.0 112.417 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -56.5 -32.86 65.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.835 1.254 . . . . 0.0 114.302 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -85.51 84.32 7.65 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 172.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -59.35 143.99 47.94 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.972 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -122.46 160.72 24.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.85 2.46 . . . . 0.0 109.118 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.0 m -87.92 155.23 19.95 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.017 0.913 . . . . 0.0 113.136 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.77 -97.17 2.07 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.307 1.432 . . . . 0.0 111.884 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.97 163.96 40.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.219 1.807 . . . . 0.0 111.388 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.6 130.23 35.75 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.435 3.423 . . . . 0.0 112.338 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -70.64 -15.4 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -66.74 106.44 1.85 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 0.0 110.801 174.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -84.75 -22.47 29.63 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.264 -0.898 . . . . 0.0 113.222 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.252 1.209 0 C-N-CA 127.351 2.26 . . . . 0.0 114.046 -179.323 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -72.08 161.15 31.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.25 1.42 . . . . 0.0 112.716 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -78.23 50.66 0.93 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.824 1.249 . . . . 0.0 111.872 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.3 mtt -115.58 68.53 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.349 2.259 . . . . 0.0 107.873 -169.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.32 -19.97 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.069 2.148 . . . . 0.0 115.087 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -89.78 8.79 30.06 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 119.802 -1.811 . . . . 0.0 113.084 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -120.98 -11.52 8.9 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.235 1.414 . . . . 0.0 111.793 171.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 43.83 2.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.452 1.901 . . . . 0.0 110.689 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 35.7 m-85 61.39 16.19 7.24 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.35 24.47 76.88 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.76 -1.578 . . . . 0.0 115.432 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.4 p -127.81 142.75 51.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.717 1.759 . . . . 0.0 112.902 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -161.66 171.32 18.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 56.16 33.79 22.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.473 1.909 . . . . 0.0 114.624 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 56.79 49.66 13.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.856 1.663 . . . . 0.0 112.411 -171.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.82 144.96 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.614 1.165 . . . . 0.0 109.764 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -96.43 70.69 2.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 125.673 2.654 . . . . 0.0 108.548 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 18' ' ' LYS 0.306 5.9 t -77.73 -176.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 110.062 -3.245 . . . . 0.0 110.644 -169.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 70.6 mmtt -42.96 -14.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.504 3.52 . . . . 0.0 120.504 -166.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.08 -16.22 56.3 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 120.945 1.702 . . . . 0.0 115.142 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 47.49 90.41 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.642 2.777 . . . . 0.0 113.564 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.13 -22.42 66.85 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.708 -1.245 . . . . 0.0 112.884 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -44.41 -37.88 3.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.564 1.546 . . . . 0.0 112.174 167.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -71.31 -43.78 66.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.027 1.331 . . . . 0.0 113.467 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -57.89 -51.66 68.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.678 0.791 . . . . 0.0 110.197 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.12 -26.84 62.28 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -62.24 -30.26 70.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.963 1.256 . . . . 0.0 113.177 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.4 73.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.574 0.625 . . . . 0.0 111.944 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.41 9.24 27.02 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.316 1.846 . . . . 0.0 112.129 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.35 2.9 p30 54.97 30.41 14.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.865 2.466 . . . . 0.0 115.724 -169.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -114.46 162.89 16.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.658 1.583 . . . . 0.0 114.035 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -75.81 152.01 37.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.554 1.542 . . . . 0.0 109.299 167.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.18 110.31 1.41 Allowed Glycine 0 N--CA 1.476 1.33 0 CA-C-N 119.37 0.986 . . . . 0.0 112.872 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 118.06 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 123.275 1.512 . . . . 0.0 112.658 -170.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -83.8 99.3 10.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.843 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -79.53 102.94 9.11 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 110.615 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.14 -123.84 21.83 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.726 1.155 . . . . 0.0 112.698 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.91 6.96 29.39 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.502 1.921 . . . . 0.0 114.52 171.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.29 172.71 8.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.474 1.91 . . . . 0.0 112.673 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.486 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . 18.9 t -130.39 150.26 51.69 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.651 0.78 . . . . 0.0 112.083 168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -130.52 161.01 32.43 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.177 2.191 . . . . 0.0 109.45 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.49 149.88 24.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.681 165.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.89 -92.15 1.5 Allowed Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.48 164.09 46.49 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.813 2.045 . . . . 0.0 110.381 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.4 141.23 91.65 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.849 2.366 . . . . 0.0 112.384 174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -20.39 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.9 m -75.08 45.24 0.26 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.023 1.729 . . . . 0.0 113.477 170.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -84.44 1.78 43.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.669 1.988 . . . . 0.0 114.299 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.023 0 C-N-CA 126.749 2.02 . . . . 0.0 113.148 -179.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 119.471 -0.3 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 51.51 -145.29 0.53 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.83 1.652 . . . . 0.0 113.126 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 147.62 8.99 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 ptm -153.95 67.31 0.74 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.386 1.875 . . . . 0.0 109.857 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.61 -14.33 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.988 2.515 . . . . 0.0 117.121 -172.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -92.35 13.85 18.19 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 119.734 -1.854 . . . . 0.0 112.221 -172.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -122.35 0.04 9.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.979 1.711 . . . . 0.0 112.497 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.08 43.7 3.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.517 2.727 . . . . 0.0 110.383 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 63.94 15.99 9.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 167.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.9 34.05 81.29 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.84 -0.978 . . . . 0.0 112.853 -170.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.15 124.61 15.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.69 1.245 . . . . 0.0 111.894 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.03 175.16 13.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 112.002 -172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.81 24.87 1.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.206 1.803 . . . . 0.0 115.398 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.81 31.71 16.14 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.921 2.088 . . . . 0.0 113.803 -170.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' CG2' ' A' ' 17' ' ' VAL . 27.1 t -89.05 168.21 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.85 1.26 . . . . 0.0 107.987 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.6 63.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 126.052 2.834 . . . . 0.0 108.096 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 6.8 t -66.81 154.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 108.871 -3.786 . . . . 0.0 110.093 -173.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -65.52 -18.38 65.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.83 -42.96 60.03 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 119.344 0.974 . . . . 0.0 113.819 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.38 148.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.386 2.274 . . . . 0.0 116.225 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.8 m -88.51 -9.5 52.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.161 1.785 . . . . 0.0 113.375 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -44.44 -45.42 9.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.023 1.729 . . . . 0.0 113.984 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -75.92 -39.12 56.87 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.058 1.343 . . . . 0.0 112.854 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -58.48 -42.22 87.05 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.009 1.324 . . . . 0.0 111.837 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.2 m -81.62 -20.28 40.05 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -33.79 68.57 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.57 1.148 . . . . 0.0 111.969 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.67 68.59 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -101.18 12.24 37.93 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.427 1.491 . . . . 0.0 111.234 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 t70 58.03 34.6 24.42 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.354 2.262 . . . . 0.0 113.539 -174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -116.29 156.05 27.32 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.194 1.398 . . . . 0.0 113.87 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.08 152.67 44.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.879 0.871 . . . . 0.0 109.351 167.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.31 131.09 8.65 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.721 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.82 146.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.479 1.111 . . . . 0.0 110.897 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.13 114.59 27.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.583 -0.698 . . . . 0.0 111.165 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -101.37 114.24 28.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.153 0.981 . . . . 0.0 111.544 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.67 -131.64 52.15 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 121.777 -0.577 . . . . 0.0 111.839 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.6 p -86.22 14.98 5.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.637 1.575 . . . . 0.0 113.793 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -135.5 164.29 28.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.917 2.087 . . . . 0.0 112.12 -171.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.1 m -99.63 146.13 26.81 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.755 -1.215 . . . . 0.0 113.408 171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -136.78 170.52 15.95 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.036 1.734 . . . . 0.0 110.387 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 40.7 m -101.34 155.55 17.98 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 174.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.45 -90.36 1.82 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.831 1.205 . . . . 0.0 112.67 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.8 m -139.64 170.27 10.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.803 2.041 . . . . 0.0 110.658 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -50.62 123.79 12.14 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 125.252 3.968 . . . . 0.0 114.674 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.39 -21.08 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.937 1.295 . . . . 0.0 113.727 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m 38.78 49.37 1.49 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.803 2.841 . . . . 0.0 116.609 167.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 45.52 36.55 2.56 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 127.607 2.363 . . . . 0.0 115.604 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp . . . . . 0 C--O 1.256 1.414 0 C-N-CA 126.603 1.961 . . . . 0.0 112.966 178.559 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -78.67 150.49 32.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.476 1.11 . . . . 0.0 112.172 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER -75.86 44.36 0.3 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.134 1.374 . . . . 0.0 114.642 -175.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -135.25 101.01 4.7 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.382 1.473 . . . . 0.0 108.517 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.2 6.15 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -169.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -113.75 -0.12 14.34 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.22 1.373 . . . . 0.0 113.651 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -127.66 -18.21 4.39 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.55 30.57 6.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 112.232 -175.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 61.66 31.32 18.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.712 0.805 . . . . 0.0 111.81 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.7 5.23 23.12 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 t -112.25 120.13 40.71 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.412 1.606 . . . . 0.0 111.341 -168.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -150.17 175.34 11.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.172 -172.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.75 29.87 8.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.895 1.678 . . . . 0.0 114.645 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 56.04 29.06 13.78 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.682 1.593 . . . . 0.0 114.604 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 16' ' ' ASP . 16.9 t -89.63 179.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.688 1.195 . . . . 0.0 109.98 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' H ' HG12 ' A' ' 15' ' ' VAL . 24.8 t70 -121.36 84.13 2.19 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 124.141 1.924 . . . . 0.0 106.528 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 15' ' ' VAL . 2.9 t -95.67 144.39 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 110.941 -2.845 . . . . 0.0 109.059 -167.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.329 9.2 mmpt? -73.82 16.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -166.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.54 -25.14 54.83 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 162.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 49.14 108.6 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.132 3.373 . . . . 0.0 116.024 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -68.98 -20.76 64.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.5 1.12 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -43.96 -44.18 7.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.285 1.434 . . . . 0.0 112.291 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -66.92 -32.68 74.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.433 1.015 . . . . 0.0 113.723 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -67.8 -46.74 71.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.698 0.799 . . . . 0.0 111.392 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.0 m -75.66 -28.49 58.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -32.3 71.33 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.24 1.416 . . . . 0.0 112.214 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.27 -19.07 65.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.192 1.397 . . . . 0.0 114.269 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.77 18.72 15.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.839 1.256 . . . . 0.0 110.717 172.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 51.39 41.17 27.97 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.558 2.343 . . . . 0.0 113.695 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -112.78 158.61 19.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.418 1.887 . . . . 0.0 111.999 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.94 151.53 33.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -118.97 122.37 5.31 Favored Glycine 0 N--CA 1.478 1.47 0 CA-C-N 119.591 1.087 . . . . 0.0 112.382 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.24 124.68 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 123.223 1.487 . . . . 0.0 113.813 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.3 89.53 7.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.071 0.948 . . . . 0.0 112.084 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -82.63 107.6 15.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.973 0.909 . . . . 0.0 111.747 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.77 -125.21 6.94 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.54 2.019 . . . . 0.0 112.85 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 p -101.94 5.59 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.347 1.459 . . . . 0.0 113.226 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -118.2 176.27 5.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.917 2.487 . . . . 0.0 110.683 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.2 t -128.11 159.11 36.11 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 173.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.75 165.89 25.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.445 2.698 . . . . 0.0 110.324 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.5 m -89.2 151.46 22.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.941 0.877 . . . . 0.0 110.851 165.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.61 -93.1 1.26 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 125.082 1.325 . . . . 0.0 111.321 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.98 165.7 34.73 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 127.135 2.174 . . . . 0.0 110.347 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.82 140.81 37.37 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.675 2.917 . . . . 0.0 111.766 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 47' ' ' TYR . 2.4 pp -68.41 -32.06 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m 47.09 35.06 3.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.517 2.327 . . . . 0.0 116.766 168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' H ' HD12 ' A' ' 45' ' ' ILE . 71.7 m-85 39.27 53.51 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 114.843 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--O 1.256 1.433 0 C-N-CA 128.861 2.864 . . . . 0.0 110.558 178.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.023 0.44 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -74.9 63.35 1.19 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -172.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -78.01 48.2 0.7 Allowed 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.127 -1.608 . . . . 0.0 112.422 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -122.29 67.49 0.94 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.371 1.069 . . . . 0.0 110.32 -171.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.07 31.79 6.93 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.947 1.299 . . . . 0.0 113.388 -167.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -125.43 -2.04 7.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.441 1.897 . . . . 0.0 113.378 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -141.71 0.37 1.43 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.58 27.24 9.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.416 1.886 . . . . 0.0 111.911 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 59.87 37.08 21.87 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.191 0.995 . . . . 0.0 111.932 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.84 7.16 11.01 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.48 -1.178 . . . . 0.0 115.115 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 t -108.33 118.17 36.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.307 1.554 . . . . 0.0 110.701 -169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -152.29 -176.33 5.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.93 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.43 30.21 6.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.864 1.265 . . . . 0.0 113.859 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.15 23.97 13.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.212 2.205 . . . . 0.0 116.356 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 16' ' ' ASP . 12.9 t -92.61 -173.0 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.352 1.072 . . . . 0.0 110.336 -173.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.64 ' H ' HG12 ' A' ' 15' ' ' VAL . 19.6 t70 -125.14 68.61 1.13 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.214 1.959 . . . . 0.0 107.091 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.23 147.83 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 110.859 -2.882 . . . . 0.0 109.971 -174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.306 4.7 mmpt? -74.03 -0.11 15.38 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -168.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.58 -23.7 76.52 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-N 119.794 1.179 . . . . 0.0 110.387 162.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.51 105.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.695 3.598 . . . . 0.0 118.959 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 t -60.48 -34.27 73.8 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.328 -1.305 . . . . 0.0 110.2 165.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -45.57 -50.16 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.749 2.02 . . . . 0.0 112.694 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -73.43 -33.88 65.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.324 1.049 . . . . 0.0 113.06 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.34 -49.06 75.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.66 0.784 . . . . 0.0 111.21 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 m -65.79 -32.06 73.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -68.4 -22.32 64.64 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.627 -1.296 . . . . 0.0 113.392 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.96 -23.62 59.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -88.66 10.35 20.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.414 1.486 . . . . 0.0 111.315 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 58.63 37.68 25.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.296 2.638 . . . . 0.0 114.237 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -126.38 164.59 20.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.958 1.303 . . . . 0.0 113.681 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -79.32 162.86 25.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 164.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.48 136.71 8.9 Favored Glycine 0 N--CA 1.468 0.787 0 CA-C-N 118.913 0.779 . . . . 0.0 112.907 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.15 138.47 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 126.356 1.863 . . . . 0.0 112.553 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.5 m -97.25 97.37 9.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 7.7 p80 -85.5 110.65 19.35 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.517 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.06 -118.94 14.22 Favored Glycine 0 CA--C 1.532 1.141 0 O-C-N 120.793 -1.192 . . . . 0.0 111.897 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.1 p -93.33 7.2 45.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.182 1.393 . . . . 0.0 113.816 169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -111.67 165.71 11.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.532 1.533 . . . . 0.0 111.907 -169.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.17 137.3 54.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.895 1.278 . . . . 0.0 112.33 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -138.54 164.06 30.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.098 1.759 . . . . 0.0 110.908 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.75 156.13 18.3 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.869 0.842 . . . . 0.0 112.935 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.15 -94.79 2.14 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.063 1.316 . . . . 0.0 111.156 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -128.43 168.44 15.67 Favored Pre-proline 0 N--CA 1.469 0.488 0 C-N-CA 126.493 1.917 . . . . 0.0 110.131 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.97 156.39 24.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.75 2.967 . . . . 0.0 115.709 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -27.54 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 p -77.82 27.67 0.17 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.854 2.061 . . . . 0.0 115.378 -170.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.45 -59.03 1.66 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.268 2.227 . . . . 0.0 110.099 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.951 1.3 . . . . 0.0 112.1 169.451 . . . . . . . . 0 0 . 1 stop_ save_